Endurant Capital Management’s PharMerica Corporation PMC Stock Holding History

Endurant Capital Management’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,390	Closed	-$232K	–	109
2016 Q2	$232K	Sell	9,390 -90,100	-91%	-$2.24M	0.08%	86
2016 Q1	$2.2M	Buy	+99,490	New	+$2.65M	0.71%	40
2015 Q2	–	Sell	-11,900	Closed	-$335K	–	114
2015 Q1	$335K	Buy	+11,900	New	+$296K	0.11%	89

Other funds holding PMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Endurant Capital Management's PMC Position: Q3 2016 in Review

Endurant Capital Management sold out of PharMerica Corporation (PMC) in Q3 2016, closing a stake of 9,390 shares — an estimated $232K sold.

Endurant Capital Management first reported a position in PMC in Q1 2015 and held it in 3 quarters. The position peaked at $2.2M in Q1 2016. 172 funds tracked by Wall St. Rank hold PMC as of Q3 2016.

Endurant Capital Management reported no remaining PharMerica Corporation position as of Q3 2016 after selling out during the quarter.
Endurant Capital Management sold 9,390 PharMerica Corporation shares in Q3 2016, an estimated $232K.
Endurant Capital Management first reported a position in PharMerica Corporation in Q1 2015 and held it in 3 quarters.
Endurant Capital Management's PharMerica Corporation position peaked at $2.2M in Q1 2016.
172 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2016.

Based on Endurant Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.